قارن الطرق
راجع الطرق التي اخترتها جنبًا إلى جنب؛ الصفوف المختلفة مميَّزة.
| مؤشر وظائف التهاب الفقار اللاصق (BASFI)× | التقييم الروتيني لبيانات مؤشر المريض 3 (RAPID3)× | |
|---|---|---|
| المجال | أمراض الروماتيزم | أمراض الروماتيزم |
| العائلة | Process / pipeline | Process / pipeline |
| سنة النشأة≠ | 1994 | 2008 |
| صاحب الطريقة≠ | Calin et al. | Pincus et al. |
| النوع | Patient-reported outcome (PRO) | Patient-reported outcome (PRO) |
| المصدر التأسيسي≠ | Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. The Journal of Rheumatology. 1994;21(12):2281-2285. link ↗ | Pincus T, Bergman MJ, Sokka T, Roth SH, Swearingen C, Yazici Y. Activity of rheumatoid arthritis is similar in patients seen in a primary care physician-based practice and in an academic rheumatology-based practice. Arthritis Care Research. 2008;59(9):1229-1236. link ↗ |
| الأسماء البديلة | BASFI, BAS-FI | RAPID3, RAPID-3 |
| ذات صلة≠ | 4 | 3 |
| الملخص≠ | The BASFI is a patient-reported outcome measure of functional disability in ankylosing spondylitis (AS), assessing physical limitations in 10 common daily activities. Introduced by Calin et al. in 1994, BASFI measures the impact of AS on quality of life and functional capacity, complementing BASDAI (disease activity). While BASDAI reflects inflammatory burden, BASFI reflects the consequences of inflammation and spinal damage on a patient's ability to perform daily tasks. BASFI is used alongside BASDAI in AS management to capture both disease activity and its functional impact. | RAPID3 is a patient-reported outcome (PRO) measure of rheumatoid arthritis disease activity based on three simple self-report items: patient-counted swollen and tender joints and overall health assessment. Introduced by Pincus et al. in 2008, RAPID3 was designed for primary care and busy practices where joint examination is impractical or time-limited. Remarkably, RAPID3 correlates strongly with clinician-examined composite measures (DAS28, CDAI, SDAI) and predicts long-term radiographic progression equally well, making it a practical alternative for resource-limited settings and self-directed monitoring. |
| ScholarGateمجموعة البيانات ↗ |
|
|